Healthcare News and Research

Latest Healthcare News and Research

INFORMS annual meeting in San Diego from October 11th to 14th

When 4,000 experts in everything from problems with California's hospitals to a perpetual game of Monopoly come to San Diego on October 11, the city will find itself deluged not only by smart people who use math for a living but also problem solvers who tackle America's greatest threats.

26 Sep 2009

ProSperus, Genesis Physicians Group launch GenPro Practice Management Solutions

ProSperus, a Mequon, Wis.,-based, full-service practice management company, and Genesis Physicians Group, a Dallas-based independent physicians association (IPA), today announced the launch of GenPro Practice Management Solutions.

26 Sep 2009

Contagious diseases more prevalent due to presenteeism

While employers may celebrate a low absenteeism rate among their employees, there may be a more serious problem if sick employees are coming to work. "Presenteeism," a new term coined for when employees work while unhealthy, may be even worse for employers and for the healthcare system, costing $160 billion annually in lost productivity, according to healthcare market research firm Kalorama Information, in its new report "The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets." The report also notes that presenteeism costs are one of many factors driving usage of wellness programs.

26 Sep 2009

Sonomax signs five year licensing agreement with Dutch company

Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that it has signed a five year licensing agreement with a newly formed Dutch company which has adopted the name Sonomax Europe BV (hereafter SEBV) with Sonomax's approval. Sonomax is not a stakeholder in SEBV.

26 Sep 2009

Symposium on ways to lower preterm birth rate

Journalists are invited to attend a gathering of the nation's leading maternal-child and quality assurance health care experts who will review and develop programs that may help lower the nation's costly preterm birth rate.

26 Sep 2009

Stelara approved by the FDA for treating psoriasis

The U.S. Food and Drug Administration today approved Stelara (ustekinumab), a biologic product for adults who have a moderate to severe form of psoriasis.

25 Sep 2009

IRIN examines how user fees have kept most vulnerable from accessing healthcare

IRIN examines how fees for medical services have kept poor populations from accessing services, in light of the recent announcement by British Prime Minister Gordon Brown that he was launching a program aimed at greatly reducing such fees in Malawi, Liberia, Sierra Leone, Ghana, Nepal and Burundi.

25 Sep 2009

Tenet Healthcare announces the completion of its registered public offering of convertible preferred stock

Tenet Healthcare Corporation (NYSE: THC) announced today that it has completed its previously announced registered public offering of 7.0% mandatory convertible preferred stock by selling 345,000 shares, including 45,000 shares sold pursuant to the underwriters' option to purchase additional shares, at a public offering price of $1,000 per share, for aggregate gross proceeds of $345 million.

25 Sep 2009

Non-AIDS-defining malignancies more prevalent among HIV-infected patients than non-HIV patients

Researchers at UT Southwestern Medical Center have found that non-AIDS-defining malignancies such as anal and lung cancer have become more prevalent among HIV-infected patients than non-HIV patients since the introduction of anti-retroviral therapies in the mid-1990s.

25 Sep 2009

State round-up: Warnings, coverage and violations in health care

Modern Healthcare: "States would have up to one year to repay the federal government a share of the money they recoup from fraudulent or improper Medicaid payments, under an amendment approved by the Senate Finance Committee. Under current law, once state inspectors identify fraudulent practices, they have 60 days to return a portion of the federal dollars back to the government. Under the new amendment, states would instead have a full year to make those payments while expanding the role of recovery audit contractors" (DoBias, 9/24).

25 Sep 2009

Kirk named to replace Kennedy, bringing Senate Democrats to crucial 60 votes

Democrats again reach 60 seats in the Senate with the announcement of Ted Kennedy's interim replacement. The Los Angeles Times reports that Massachusetts Gov. Deval Patrick "named Paul Kirk Jr., a former Democratic National Committee chairman and close friend and former aide of the late Sen. Edward M. Kennedy, to serve as a temporary replacement for the deceased senator until a special election for the seat is held in January."

25 Sep 2009

NIH calls for identifying better methods to predict the risk of developing breast cancer

Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.

25 Sep 2009

Recipients of the Lundbeck Neonatal Nursing Career Path Scholarship announced

The National Association of Neonatal Nurses (NANN) is proud to announce the recipients of the Lundbeck Neonatal Nursing Career Path Scholarship. The program, made possible through a grant from Lundbeck Inc. (formerly Ovation Pharmaceuticals), supports clinical neonatal nurses who seek to advance their education and become neonatal nurse practitioners.

25 Sep 2009

On quality of care, U.S. is not always best

The Washington Post interviewed Sen. Kent Conrad, D-N.D., about other developed nations' health care systems: "We won't adopt the German system or French system or anything of the like. But I think we can get clues on the fundamental differences of various systems," he said. Conrad added that the system that has "largely been adopted in France, Germany, Japan, Belgium and Switzerland, is not government-run.

25 Sep 2009

Joseph Gunnar retained as Medical Connections' exclusive investment banker

Medical Connections Holdings, Inc., one of the nation’s fastest growing healthcare staffing companies specializing in allied health, nurse and physician staffing and recruiting services, is pleased to announce it has retained New York City-based broker dealer Joseph Gunnar & Co as its exclusive investment banker.

25 Sep 2009

Hamilton Health Sciences contravening the collective agreement: Registered nurses of ONA

Thirty-seven registered nurses, members of the Ontario Nurses' Association (ONA) will attend an arbitration hearing in Hamilton tomorrow that will decide whether Hamilton Health Sciences will be allowed to continue to arbitrarily reassign nurses to other vacant positions within the hospital.

25 Sep 2009

Dyax to present an update of its clinical development programs

Dyax Corp., a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare Focus Conference, being held October 5-6th at The New York Palace Hotel in New York City, NY.

25 Sep 2009

AABM Team wins two medals in a national contest

The Aquatic Animal Bio-Medicine R&D Team (AABM Team) of National Cheng Kung University (NCKU) in Taiwan, led by Distinguished Prof. Huey-Lang Yang from Institute of Biotechnology, won two medals out of more than 100 teams in the national contest, “2009 Crazy Idea – King of Practical Applications on Creative Researches and Development of Biotechnology,” organized by the Industrial Development Bureau of the Ministry of Economic Affairs, Taiwan.

25 Sep 2009

ethica Clinical Research, Matrix Pharma sign worldwide agreement

ethica Clinical Research Inc. ("ethica"), a Contract Research Organization (CRO) headquartered in Montreal, and Matrix Pharma Canada Inc. ("Matrix Pharma"), have announced the signing of an agreement, valued at CAD1.25 Million, that provides ethica with an exclusive, worldwide license to promote and use Matrix Pharma's proprietary research data analysis technology for life sciences applications, notably for the identification and optimization of biomarkers.

25 Sep 2009

First Edition: September 25, 2009

Today's headlines reflect the continuing action in the Senate Finance Committee and around Congress, focusing on legislative strife related to the White House deal with drug companies and the debate over the public plan.

25 Sep 2009